Research Article
Prognostic Value of Oxidative Stress Markers in Patients with Pulmonary Arterial or Chronic Thromboembolic Pulmonary Hypertension
Table 2
Haemodynamic data and specific treatment.
| | Parameter | PAH () | CTEPH () |
| | Haemodynamic parameters, median, IQR | | | | mPAP (mmHg) | 44.5 (35.5-52.5) | 36.0 (29.0-41.0) | | PVR (Wood units) | 469 (354.0-652.7) | 264 (218.3-419.6) | | CI (L/min/m2) | 3.3 (2.96-4.05) | 3.52 (3.13-4.07) | | mRAP (mmHg) | 6.4 (4.5-7.0) | 5.0 (4.0-8.0) | | SatO2mix (%) | 72.3 (66.076.8) | 75.8 (70.8-79.4) | | PAH and CTEPH specific treatment | | | | Monotherapy (, %) | | | | Riociguat | 1 (4) | 16 (94) | | Sildenafil | 4 (14) | 0 (0) | | Bosentan | 4 (14) | 0 (0) | | Macicentan | 1 (4) | 0 (0) | | Combined therapy (, %) | | | | Sildenafil+treprostinil sc | 6 (21) | 0 (0) | | Sildenafil+macicentan | 3 (11) | 0 (0) | | Sildenafil+iloprost | 2 (7) | 0 (0) | | Sildenafil+bosentan | 1 (4) | 0 (0) | | Sildenafil+iloprost+bosentan | 4 (14) | 0 (0) | | Sildenafil+oral treprostinil+macicentan | 1 (4) | 0 (0) | | Sildenafil+oral treprostinil | 1 (4) | | | Baloon pulmonary angioplasty | 0 (0) | 15 (88) |
|
|
mPAP: mean pulmonary artery pressure; PVR: pulmonary vascular resistance; CI: cardiac index; mRAP: mean right atrium pressure; SatO2mix: mixed venous oxygen saturation; PAH: pulmonary arterial hypertension; CTEPH: chronic thromboembolic pulmonary hypertension.
|
